The Global Health Body Raises Warning Over Acute Shortage of Weight-Loss Medications
Under 10% of individuals eligible to benefit from obesity jabs like Wegovy can access them, caution the World Health Organization as it publishes its first recommendations on the therapies.
Given in excess of 1,000,000,000 individuals worldwide now living with obesity, it is calling for broader and more equitable availability to GLP-1 medication.
Per forecasts, more than two billion could be obese by 2030 unless action is taken.
"The latest guidelines recognises that obesity is a long-term condition that can be managed with comprehensive and lifelong support," stated WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and supply-chain constraints are key hurdles to universal availability to the injections that can help people shift considerable weight, explains the body.
Weight-Loss Drug Scarcity
Even in the current best projected case, the manufacturing of these medications would only suffice for approximately 100 million people – less than 10% of those who need them, according to the health organization.
The guideline urges governments and firms to widen availability, by strategies including voluntary licensing.
The intellectual property rights on semaglutide – the core ingredient of a leading brand – is scheduled to end in several nations in 2026.
How Weight-Loss Jabs Operate
GLP-1 drugs mimick a natural hormone to delay gastric emptying, reduce hunger and increase satiety so users reduce food intake.
Individuals commonly begin shedding pounds after several weeks of beginning the regular doses.
Studies points to users may regain a significant portion within a year of discontinuing the treatment, because their usual appetite come back.
To be above a healthy weight elevates your likelihood for contracting health problems, like diabetes, cardiovascular issues, stroke, and some cancers.
Excess weight impacts individuals in all nations and was associated with over three and a half million deaths worldwide in 2024, per the health agency.
